http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_945124ad2fe09ac27065bc84ccb1019f
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Klein-Szanto |
| name | Andres J Klein-Szanto Andres J. Klein-Szanto |
| given-name | Andres J. Andres J |
| organization-name | Authors' Affiliations: 1Cancer Biology Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania; 2Burnett School of Biomedical Sciences, University of Central Florida, Orlando, Florida; 3Verastem Inc., Cambridge, Massachusetts; and 4Cancer Research Institute, Southern Medical University, Guangdong Province, PR China 1Cancer Biology Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania.; 2Histopathology Facility, Fox Chase Cancer Center, Philadelphia, Pennsylvania. Ovarian Cancer Programs, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA; Department of Pathology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA Authors' Affiliations: 1Gastroenterology Division, Department of Medicine, Departments of 2Otorhinolaryngology-Head and Neck Surgery and 3Cancer Biology, 4Division of Biostatistics, Center for Clinical Epidemiology and Biostatistics, and 5Abramson Cancer Center, University of Pennsylvania; 6Department of Pathology, Fox Chase Cancer Center; 7Wistar Institute, Philadelphia, Pennsylvania; 8Division of Gastroenterology and Hepatology, Digestive Disease Center, The Tazuke Kofukai Medical Research Institute Kitano Hospital, Osaka; 9Division of Tumor Pathology, Department of Pathological Sciences, School of Medicine, Faculty of Medical Sciences, University of Fukui, Eiheiji, Fukui, Japan; and 10Department of Oral Health and Rehabilitation, University of Louisville School of Dentistry, Louisville, Kentucky Department of Pathology, Fox Chase Cancer Center, Philadelphia, PA, USA; Cancer Biology Program, Fox Chase Cancer Center, Philadelphia, PA, USA Department of Pathology; Fox Chase Cancer Center; Philadelphia Pennsylvania; Cancer Biology Program; Fox Chase Cancer Center; Philadelphia Pennsylvania Authors' Affiliations: 1Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine; 2Department of Obstetrics and Gynecology, Osaka Police Hospital; 3Department of Obstetrics and Gynecology, Osaka Medical College, Osaka, Japan; 4Women's Cancer Program, 5Cancer Genetics and Signaling Program, and 6Department of Surgery, Fox Chase Cancer Center, Philadelphia, Pennsylvania; and 7Department of Obstetrics and Gynecology, Kansai Rosai Hospital, Amagasaki, Japan Authors' Affiliations: 1Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, 2Department of Pathology, Osaka Police Hospital, and 3Department of Obstetrics and Gynecology, Osaka Medical College, Osaka, Japan; 4Women's Cancer Program, 5Cancer Genetics and Signaling Program, and 6Molecular Medicine Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania; and 7Department of Obstetrics and Gynecology, Wakayama Rosai Hospital, Wakayama, Japan Authors' Affiliations: 1Program in Developmental Therapeutics, 2Genomics Facility, and 3Department of Pathology, Fox Chase Cancer Center, Philadelphia, Philadelphia; 4Department of Medicine and Cancer Center, University of Illinois at Chicago, Chicago, Illinois; 5Department of Pharmaceutical Sciences, College of Pharmacy and Allied Health Professionals, St John's University, Jamaica, New York; 6Department of Dermatology, Xiang Ya Hospital, Central South University, Changsha, China; and 7National Institute of Child Health and Human Development, NIH, Bethesda, Maryland Histopathology Facility, Fox Chase Cancer Center, Philadelphia, PA, USA Department of Histopathology; Fox Chase Cancer Center; Philadelphia, PA, USA Department of Pathology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA Department of Pathology, Fox Chase Cancer Center Philadelphia, PA, USA. Histopathology Facility and Cancer Biology Program, Fox Chase Cancer Center Philadelphia, PA, USA. 1Cancer Biology Program, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, Pennsylvania.; 8Histopathology Facility, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, Pennsylvania. Histopathology Facility, Fox Chase Cancer Center , Philadelphia, PA 19111 , USA Authors' Affiliations: Departments of 1Developmental Therapeutics, 2Pathology, and 3Biostatistics, Fox Chase Cancer Center, Philadelphia, Pennsylvania and 4Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel Authors' Affiliations: 1Women's Cancer and 2Cancer Genetics and Signaling Programs, Fox Chase Cancer Center, Philadelphia, Pennsylvania; 3Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, New York; and 4Oncology Biology, GlaxoSmithKline, Collegeville, Pennsylvania Department of Pathology, Fox Chase Cancer Center, Philadelphia, PA 19111; Fox Chase Cancer Center, Philadelphia, Pennsylvania Histopathology Facility, Fox Chase Cancer Center , Philadelphia, PA , USA From the Fox Chase Cancer Center, Philadelphia, PA; Gynecologic Oncology Group Statistical and Data Center; University at Buffalo, Buffalo, NY; Tacoma General Hospital, Tacoma, WA; University of Ottawa, Ottawa, Ontario, Canada; Centre for Cancer Therapeutics, Ottawa Health Research Institute, Ottawa, Ontario, Canada Authors' Affiliations: 1Division of Gastroenterology, Departments of 2Medicine, 3Genetics, and 4Cancer Biology, 5Abramson Cancer Center, and 6Division of Biostatistics, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania; 7Division of Basic Science, Tumor Cell Biology, Fox Chase Cancer Center; and 8Wistar Institute, Philadelphia, Pennsylvania; and 9Departent of Systems Biology, M.D. Anderson Cancer Center, Houston, Texas 3Fox Chase Cancer Center, Philadelphia, Pennsylvania. Authors' Affiliations: 1Gastroenterology Division, Department of Medicine; Departments of 2Genetics and 3Cancer Biology; and 4Abramson Cancer Center, University of Pennsylvania; 5Department of Pathology, Fox Chase Cancer Center; and 6Wistar Institute, Philadelphia, Pennsylvania 2Histopathology Facility, Fox Chase Cancer Center, Philadelphia, Pennsylvania. 3Department of Pathology, Fox Chase Cancer Center, Philadelphia, Pennsylvania; Departments of Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111-2497; |
Incoming Links
Total number of triples: 118.